A single-scan protocol for absolute D2/3 receptor quantification with [123I]IBZM SPECT

Purpose: Molecular imaging of the D2/3 receptor is widely used in neuropsychiatric research. Non‐displaceable binding potential (BPND) is a very popular quantitative index, defined as the product of the receptor concentration (Bavail) and the radiotracer affinity for the receptor (1/appKd). As the appKd is influenced by parameters such as the endogenous neurotransmitter dynamics, it often constitutes a confounding factor in research studies. A simplified method for absolute quantification of both these parameters would be of great interest in this context. Here, we describe the use of a partial saturation protocol that permits to produce an in vivo Scatchard plot and thus estimate Bavail and appKd separately, through a single dynamic SPECT session. To validate this approach, a multi‐injection protocol is used for the full kinetic modeling of [123I]IBZM using a 3‐tissue compartment, 7‐parameter model (3T‐7k). Finally, more “classic” BPND estimation methods are also validated against the results of the 3T‐7k. Methods: Twenty‐nine male rats were used. Binding parameters were estimated using the 3T‐7k in a multi‐injection protocol. A partial saturation protocol was applied at the region‐ and voxel‐level and results were compared to those obtained with the 3T‐7k model. The partial saturation protocol was applied after an adenovirus‐mediated D2 receptor striatal overexpression and in an amphetamine‐induced dopamine release paradigm. The Simplified Reference Tissue Model (SRTM), the Logan's non‐invasive graphical analysis (LNIGA) and a simple standardized uptake ratio (SUR) method were equally applied. Results: The partial saturation experiments gave similar values as the 3T‐7k both at the regional and voxel‐level. After adenoviral‐mediated D2‐receptor overexpression, an increase in Bavail by approximately 18% was observed in the striatum. After amphetamine administration, a 16.93% decrease in Bavail (p<0.05) and a 39.12% increase (p<0.01) in appKd was observed. BPND derived from SRTM, LNIGA and SUR correlated well with the Bavail values from the 3T‐7k (r=0.84, r=0.84 and r=0.83, respectively, p<0.0001 for all correlations). Conclusion: A partial saturation protocol permits the non‐invasive and time‐efficient estimation of Bavail and appKd separately. Given the different biological phenomena that underlie these parameters, this method may be applied for the in‐depth study of the dopaminergic system in translational molecular imaging studies. It can detect the biological variations in these parameters, dissociating the variations in receptor density (Bavail) from affinity (1/appKd), which reflects the interactions of the receptor with its endogenous ligand. HIGHLIGHTSResearch suggests dissociative changes in Bavail and appKd of neuroreceptors.Currently these parameters are jointly estimated as binding potential (BP).A single‐scan non‐invasive protocol for separate estimation is proposed.Sufficient sensitivity for biological studies is validated.Endogenous transmitter level assessed through appKd estimation.

[1]  Vincent J. Cunningham,et al.  Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.

[2]  S. D. Glick,et al.  Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats , 2003, Psychopharmacology.

[3]  P B Hoffer,et al.  Microdialysis and SPECT measurements of amphetamine‐induced dopamine release in nonhuman primates , 1997, Synapse.

[4]  Sylvain Houle,et al.  Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats , 2004, Biological Psychiatry.

[5]  J Delforge,et al.  Quantitation of benzodiazepine receptors in human brain using the partial saturation method. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Nathalie Ginovart,et al.  Imaging the Dopamine System with In Vivo [11C]raclopride Displacement Studies: Understanding the True Mechanism , 2005, Molecular Imaging and Biology.

[7]  Philippe Millet,et al.  Evaluation of the Reference Tissue Models for PET and SPECT Benzodiazepine Binding Parameters , 2002, NeuroImage.

[8]  N. Volkow,et al.  Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers , 2016, Translational Psychiatry.

[9]  N. Ginovart,et al.  In Vivo Quantification of 5-HT2A Brain Receptors in Mdr1a KO Rats with 123I-R91150 Single-Photon Emission Computed Tomography , 2015, Molecular imaging.

[10]  José Guimón,et al.  Wavelet Analysis of Dynamic PET Data: Application to the Parametric Imaging of Benzodiazepine Receptor Concentration , 2000, NeuroImage.

[11]  D J Brooks,et al.  Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  G. Arbuthnott,et al.  Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study , 1988, Journal of neurochemistry.

[13]  N. Harada,et al.  Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [ 11 C ]raclopride?: PET studies combined with microdialysis in conscious monkeys , 1999, Brain Research.

[14]  Mark Slifstein,et al.  The nature of dopamine dysfunction in schizophrenia and what this means for treatment. , 2012, Archives of general psychiatry.

[15]  G. Searle,et al.  The Simplified Reference Tissue Model: Model Assumption Violations and Their Impact on Binding Potential , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  Nora D. Volkow,et al.  Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment , 2009, NeuroImage.

[17]  J. Schiefer,et al.  Cerebral kinetics of the dopamine D(2) receptor ligand [(123)I]IBZM in mice. , 2008, Nuclear medicine and biology.

[18]  François Mauguière,et al.  Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. , 2005, Brain : a journal of neurology.

[19]  Jeih-San Liow,et al.  Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein , 2015, The Journal of Nuclear Medicine.

[20]  Doris J Doudet,et al.  Sequential Versus Nonsequential Measurement of Density and Affinity of Dopamine D2 Receptors with [11C]raclopride: Effect of Methamphetamine , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Mitul A. Mehta,et al.  The dopaminergic basis of human behaviors: A review of molecular imaging studies , 2009, Neuroscience & Biobehavioral Reviews.

[22]  N. Alpert,et al.  Concentration of dopamine transporters: To Bmax or not to Bmax? , 1999, Synapse.

[23]  M. Grégoire,et al.  In Vivo Measurement of Hippocampal GABAA/cBZR Density with [18F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy , 2014, PloS one.

[24]  Mary L. Schneider,et al.  The effects of chronic alcohol self-administration on serotonin-1A receptor binding in nonhuman primates. , 2014, Drug and alcohol dependence.

[25]  B Walder,et al.  Similarity and Robustness of PET and SPECT Binding Parameters for Benzodiazepine Receptors , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  L Cinotti,et al.  Parameter and index images of benzodiazepine receptor concentration in the brain. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  Philippe Millet,et al.  Quantification of dopamine D2/3 receptors in rat brain using factor analysis corrected [18F]Fallypride images , 2012, NeuroImage.

[28]  S. Kapur,et al.  Role of dopamine D(2) receptors for antipsychotic activity. , 2012, Handbook of experimental pharmacology.

[29]  Multiinjection Approach for D2 Receptor Binding Quantification in Living Rats using [11C]Raclopride and the β-Microprobe: Crossvalidation with in Vitro Binding Data , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  J. Delforge,et al.  Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data , 1990, IEEE Transactions on Biomedical Engineering.

[31]  J. P. Bazin,et al.  Handling of Dynamic Sequences in Nuclear Medicine , 1982, IEEE Transactions on Nuclear Science.

[32]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  N. Ginovart,et al.  Quantification of GABAA receptors in the rat brain with [(123)I]Iomazenil SPECT from factor analysis-denoised images. , 2014, Nuclear medicine and biology.

[34]  Philippe Millet,et al.  In vivo quantification of 5-HT1A–[18F]MPPF interactions in rats using the YAP-(S)PET scanner and a β-microprobe , 2008, NeuroImage.

[35]  Frank Telang,et al.  Sleep Deprivation Decreases Binding of [11C]Raclopride to Dopamine D2/D3 Receptors in the Human Brain , 2008, The Journal of Neuroscience.

[36]  M Slifstein,et al.  Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions. , 2000, Nuclear medicine and biology.

[37]  D. Sibley,et al.  Dopamine β‐hydroxylase‐deficient mice have normal densities of D2 dopamine receptors in the high‐affinity state based on in vivo PET imaging and in vitro radioligand binding , 2010, Synapse.

[38]  F. Beekman,et al.  SPECT imaging of D2 dopamine receptors and endogenous dopamine release in mice , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[39]  J. Holden,et al.  Sequential versus Nonsequential Measurement of Density and Affinity of Dopamine D2 Receptors with [11C]Raclopride: 2: Effects of DAT Inhibitors , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[41]  N. Verhoeff,et al.  In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[42]  Frederic Boisson,et al.  Simulation-based optimisation of the PET data processing for Partial Saturation Approach protocols , 2014, NeuroImage.

[43]  Mary L. Schneider,et al.  Measurement of 5-HT1A Receptor Density and in-vivo Binding Parameters of [18F]mefway in the Nonhuman Primate , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  Dean F. Wong,et al.  Dissociative Changes in the Bmax and KD of Dopamine D2/D3 Receptors with Aging Observed in Functional Subdivisions of the Striatum: A Revisit with an Improved Data Analysis Method , 2012, The Journal of Nuclear Medicine.

[45]  M. Laruelle,et al.  Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naïve Schizophrenic Subjects , 2009, Biological Psychiatry.

[46]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[47]  P. Millet,et al.  SPECT quantification of benzodiazepine receptor concentration using a dual-ligand approach. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[48]  S. Kapur,et al.  In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone. , 2003, Molecular pharmacology.

[49]  Dennis Hernaus,et al.  The dopaminergic response to acute stress in health and psychopathology: A systematic review , 2015, Neuroscience & Biobehavioral Reviews.

[50]  Diana Martinez,et al.  Cocaine abuse and sensitization of striatal dopamine transmission: A critical review of the preclinical and clinical imaging literature , 2008, Synapse.

[51]  C. Louapre,et al.  The neuronal component of gray matter damage in multiple sclerosis: A [11C]flumazenil positron emission tomography study , 2015, Annals of neurology.

[52]  C. Svarer,et al.  High trait aggression in men is associated with low 5-HT levels, as indexed by 5-HT4 receptor binding. , 2016, Social cognitive and affective neuroscience.

[53]  N. Volkow,et al.  Imaging dopamine's role in drug abuse and addiction , 2009, Neuropharmacology.

[54]  S. Zoghbi,et al.  Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil. , 1994, Journal of pharmaceutical sciences.

[55]  D. Segal,et al.  Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[56]  N. Volkow,et al.  Dopamine D2 Receptor Availability in Opiate-Dependent Subjects before and after Naloxone-Precipitated Withdrawal , 1997, Neuropsychopharmacology.

[57]  J. Delforge,et al.  Parametric Images of Benzodiazepine Receptor Concentration Using a Partial-Saturation Injection , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[58]  J Delforge,et al.  Experimental design optimisation: theory and application to estimation of receptor model parameters using dynamic positron emission tomography. , 1989, Physics in medicine and biology.

[59]  5-HT2A receptor SPECT imaging with [¹²³I]R91150 under P-gp inhibition with tariquidar: More is better? , 2016, Nuclear medicine and biology.

[60]  J. Schiefer,et al.  Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice. , 2008, Nuclear medicine and biology.

[61]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[62]  W. van den Brink,et al.  Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats. , 2012, Nuclear medicine and biology.

[63]  S. Kapur,et al.  Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. , 2009, Current pharmaceutical design.

[64]  Alan A. Wilson,et al.  Positron Emission Tomography Quantification of [11C]-DASB Binding to the Human Serotonin Transporter: Modeling Strategies , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[65]  L. Howell,et al.  Neuroimaging and drug taking in primates , 2011, Psychopharmacology.

[66]  Anat Biegon,et al.  Serial microPET measures of the metabolic reaction to a microdialysis probe implant , 2006, Journal of Neuroscience Methods.

[67]  A. Malhotra,et al.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Swen Hesse,et al.  Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: A critical evaluation of the single-scan approach , 2008, NeuroImage.

[69]  Doris J Doudet,et al.  Raclopride studies of dopamine release: dependence on presynaptic integrity , 2003, Biological Psychiatry.

[70]  Bernard Bendriem,et al.  Quantitation of Extrastriatal D2 Receptors Using a Very High-Affinity Ligand (FLB 457) and the Multi-Injection Approach , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[71]  Anthonin Reilhac,et al.  A data driven method for estimation of Bavail and appKD using a single injection protocol with [11C]raclopride in the mouse , 2014, NeuroImage.

[72]  N. Volkow,et al.  Association between striatal dopamine D2/D3 receptors and brain activation during visual attention: effects of sleep deprivation , 2016, Translational psychiatry.

[73]  C. Antke,et al.  Binding of [123I]iodobenzamide to the rat D2 receptor after challenge with various doses of methylphenidate: an in vivo imaging study with dedicated small animal SPECT , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[74]  Doris J Doudet,et al.  In Vivo Measurement of Receptor Density and Affinity: Comparison of the Routine Sequential Method with a Nonsequential Method in Studies of Dopamine D2 Receptors with [11C]Raclopride , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[75]  Sonja W. Scholz,et al.  Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats , 2005, NeuroImage.

[76]  M. Laruelle Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[77]  R. Innis,et al.  Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders , 2000, Annals of nuclear medicine.

[78]  Robert B. Innis,et al.  Serotonin-1A receptors in major depression quantified using PET: Controversies, confounds, and recommendations , 2012, NeuroImage.

[79]  Bernard Bendriem,et al.  Modeling Analysis of [11C]Flumazenil Kinetics Studied by PET: Application to a Critical Study of the Equilibrium Approaches , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[80]  M. Slifstein,et al.  Deficits in Dopamine D2 Receptors and Presynaptic Dopamine in Heroin Dependence: Commonalities and Differences with Other Types of Addiction , 2012, Biological Psychiatry.

[81]  J. Swanson,et al.  Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. , 2007, Archives of neurology.

[82]  Bradley T. Christian,et al.  5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate , 2013, NeuroImage.